Elutia Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
ELUT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
12510 Prosperity Drive, Suite 370, Silver Spring, Maryland

There are no Buy or Sell transactions made by insiders since 7/18/2023

Elutia Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
HighCape Capital, LLC 10%+ Owner $16.9 M Dec 28, 2023
HighCape Capital, L.P. Director, 10%+ Owner $16.9 M Dec 28, 2023
Birchview Capital, LP 10% Owner in previous filing $3.99 M Dec 31, 2023
Elutia PIPE Investment, LP 10%+ Owner $3.46 M Sep 21, 2023
HighCape Partners GP II, LLC 10%+ Owner $1.77 M Dec 22, 2022
Matthew Ferguson Chief Financial Officer $964 K Jun 10, 2024
C. Randal Mills PRESIDENT AND CEO, Director $611 K Jun 21, 2024
Michelle LeRoux Williams Chief Scientific Officer $493 K Jun 10, 2024
Ronald K. Lloyd PRESIDENT AND CEO, Director $173 K Mar 8, 2022
Darryl Roberts Evp, Operations & Product Dev. $49.1 K Mar 8, 2022
Thomas Englese Chief Commercial Officer $47.7 K Mar 8, 2023
Jerome Riebman Chief Medical Officer $36.1 K Sep 8, 2022
Peter G. Edwards General Counsel $8.43 K Sep 8, 2022
Matt Zuga Director, 10%+ Owner Jun 6, 2024
Maybelle Jordan Director Jun 6, 2024
David Colpman Director Jun 6, 2024
Brigid Makes Director Jun 6, 2024
Kevin Rakin Director, 10%+ Owner Jun 6, 2024

Recent Insider Transactions by Companies or Individuals for Elutia Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership